SCHEMBL24228758

SCHEMBL24228758

COc1ccc(C2Sc3ccccc3N2CCCF)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CACNA1S Q13698 2/20 0.43
▸ TP53 P04637 1/20 0.42
▸ THRB P10828 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ PTGS1 P23219 1/20 0.40
▸ PTGS2 P35354 1/20 0.40
▸ HDAC3 O15379 1/20 0.40
▸ HDAC4 P56524 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC7 Q8WUI4 1/20 0.40
▸ HDAC2 Q92769 1/20 0.40
▸ HDAC10 Q969S8 1/20 0.40
▸ HDAC11 Q96DB2 1/20 0.40
▸ HDAC8 Q9BY41 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ HDAC9 Q9UKV0 1/20 0.40
▸ HDAC5 Q9UQL6 1/20 0.40
▸ GSK3B P49841 2/20 0.40
▸ MAPT P10636 1/20 0.40
▸ GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29373482 1.00 CACNA1S (0.43) CACNA1STP53THRBSMN1; SMN2PTGS1
Hydrochloric Acid SCHEMBL29370572 0.99 CACNA1S (0.42) CACNA1STP53THRBSMN1; SMN2PTGS1
SCHEMBL24228679 0.89 CYP3A4 (0.45) CACNA1STP53THRBSMN1; SMN2PTGS1
SCHEMBL30445533 0.88 CACNA1S (0.43) CACNA1STP53THRBSMN1; SMN2PTGS1
SCHEMBL24228678 0.88 CACNA1S (0.43) CACNA1STP53THRBSMN1; SMN2PTGS1
SCHEMBL24228688 0.85 GSK3B (0.35) TP53SMN1; SMN2GSK3B
SCHEMBL29373153 0.85 GSK3B (0.35) TP53SMN1; SMN2GSK3B
SCHEMBL24228689 0.74 KDM1A (0.40) GSK3BGAATSHRALDH1A1MEN1
SCHEMBL24228687 0.72 GSK3B (0.35) TP53SMN1; SMN2GSK3BGAA
SCHEMBL30445676 0.72 GSK3B (0.35) TP53SMN1; SMN2GSK3BGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230263915-A1 RADIOLABELED COMPOUNDS KING'S COLLEGE LONDON (GB) 2023-08-24 — — US disclosed
US-20230263915-A1 RADIOLABELED COMPOUNDS KING'S COLLEGE LONDON (GB) 2023-08-24 — — US disclosed
CN-116322673-A Radiolabeled compounds 伦敦国王学院 2023-06-23 — — CN disclosed
WO-2022023439-A1 RADIOLABELED COMPOUNDS KING'S COLLEGE LONDON (GB) 2022-02-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230263915-A1 RADIOLABELED COMPOUNDS TMEM14C, PIGO, SLCO1B1 CACNA1S 4555/4885TP53 993/4885THRB 1381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback